Prot #M15-656: A Randomized, Double-Blind, Placebo Controlled Study of Venetoclax in Combination with Azacitidine Versus Azacitidine in Treatment Naïve Subjects with Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Therapy

Project: Research project

Project Details

StatusActive
Effective start/end date2/14/182/14/22

Funding

  • AbbVie Inc. (Prot #M15-656)